[Total glucosides of paeony inhibits proliferation and promotes activation- induced cell death of mouse T cells
Bcl-2
Fas/FasL
activation-induced cell death
proliferation
total glucosides, paeony
Journal
Nan fang yi ke da xue xue bao = Journal of Southern Medical University
ISSN: 1673-4254
Titre abrégé: Nan Fang Yi Ke Da Xue Xue Bao
Pays: China
ID NLM: 101266132
Informations de publication
Date de publication:
30 Jan 2020
30 Jan 2020
Historique:
entrez:
8
5
2020
pubmed:
8
5
2020
medline:
1
7
2020
Statut:
ppublish
Résumé
To investigate the effects of total glucosides of paeony (TGP) on the proliferation and activation-induced cell death of mouse T cells and the mechanism underlying the immunosuppressive effects of TGP. Purified total T cells isolated from the spleen of C57BL/6 mice were treated with TGP at 0, 50, 100, or 200 μg/mL and stimulated by anti-CD3/ CD28. Flow cytometry was performed to detect the cell death and the proliferation of CFSE-labeled T cells. The expression of Fas/FasL mRNA was detected using RT-PCR, and flow cytometry was used to analyze the expression of Fas/FasL proteins on activated T cells. Western blotting was used to detect the expression of Bcl-2 in the cells. TGP treatment for 48 h significantly reduced the total number and percentage of viable T cells and dose-dependently lowered the percentage of divided T cells. TGP treatment obviously up-regulated the cellular expression of Fas mRNA, enhanced Fas expression on the surface of the T cells, and decreased the expression level of Bcl-2 protein in the cells. TGP significantly inhibits proliferation and promotes activation-induced cell death of mouse T cell by increasing the expression of Fas and downregulating the expression of Bcl-2.
Identifiants
pubmed: 32376553
doi: 10.12122/j.issn.1673-4254.2020.01.19
pmc: PMC7040747
doi:
Substances chimiques
Fas Ligand Protein
0
Fas protein, mouse
0
Fasl protein, mouse
0
Glucosides
0
Proto-Oncogene Proteins c-bcl-2
0
fas Receptor
0
Bcl2 protein, mouse
114100-40-2
Types de publication
Journal Article
Langues
chi
Sous-ensembles de citation
IM
Pagination
118-124Références
Nature. 1995 Feb 2;373(6513):444-8
pubmed: 7530337
Cell Immunol. 2012 Dec;280(2):156-63
pubmed: 23399842
Korean J Physiol Pharmacol. 2014 Feb;18(1):73-8
pubmed: 24634600
Cell. 1991 Nov 29;67(5):889-99
pubmed: 1959134
Cell Immunol. 2006 Feb;239(2):121-8
pubmed: 16808908
Int Rev Cell Mol Biol. 2018;341:125-168
pubmed: 30262031
Blood. 2015 Sep 10;126(11):1314-23
pubmed: 26138686
J Autoimmun. 2017 Aug;82:47-61
pubmed: 28551033
Front Immunol. 2017 Sep 27;8:1216
pubmed: 29021794
Nat Protoc. 2007;2(9):2049-56
pubmed: 17853860
Biochem Pharmacol. 2019 Apr;162:250-261
pubmed: 30668936
Clin Exp Rheumatol. 2007 Sep-Oct;25(5 Suppl 46):S4-11
pubmed: 17977483
Immunol Rev. 2003 Jun;193:70-81
pubmed: 12752672
Methods Mol Biol. 2017;1557:219-228
pubmed: 28078597
Curr Opin Immunol. 2002 Jun;14(3):354-9
pubmed: 11973134
Curr Opin Rheumatol. 2005 Sep;17(5):518-22
pubmed: 16093827
J Immunol. 1995 Apr 15;154(8):3806-13
pubmed: 7706720
Immunity. 2005 May;22(5):534-5
pubmed: 15894270
Clin Immunol. 2012 May;143(2):180-7
pubmed: 22406048
Crit Rev Immunol. 2014;34(4):301-14
pubmed: 24941158
Clin Lab Med. 2017 Sep;37(3):527-546
pubmed: 28802499
Cell Mol Immunol. 2004 Jun;1(3):186-92
pubmed: 16219166
Curr Diab Rep. 2016 May;16(5):40
pubmed: 26983628
Mol Med Rep. 2017 Dec;16(6):8265-8276
pubmed: 28944916
Immunity. 2009 Apr 17;30(4):611
pubmed: 19378493